top of page
main_color_v2.png

Centre for Oncology and Immunology Fifth Symposium

Immunotherapy for Cancer Treatment: Breakthroughs and Innovations

28 February 2025 (Friday), 9:00 AM - 6:00 PM
Grand Hall, Hong Kong Science and Technology Park
Welcome to COI's 5th Symposium, "Immunotherapy for Cancer Treatment: Breakthroughs and Innovations", an event that will bring together leading scientists and industry experts to discuss the latest advancements in cancer immunotherapy. This symposium will showcase groundbreaking research and innovative approaches aimed at harnessing the power of the immune system to combat cancer. Our symposium features stimulating presentations and thought-provoking panel discussions that will provide valuable insights into the future of cancer treatment. Don't miss this opportunity to engage with top professionals from around the world, exchange ideas, and foster collaborations.
hku-coi-rgb white (1)_edited.png
Speakers

Speakers

Mark Davis_ without background_edited_edited_edited_edited_edited.png

Prof. Mark Davis

Director

Stanford Institute for Immunity, Transplantation and Infection, Stanford University

 

Professor

Microbiology and Immunology, 

Stanford University

Hai Qi_without background'.png

Prof. Hai Qi 祁海教授

Executive Vice-Chancellor

School of Medicine, Tsinghua University

Professor

School of Medicine, Tsinghua University

Qiang Pan_without background.png

Prof. Qiang Pan-Hammarström

Professor
Department of Medical Biochemistry and Biophysics, Karolinska Institutet

 
Stephen Schoenberger_without background_edited.png

Prof. Stephen Schoenberger

Professor

La Jolla Institute for Immunology

Prof_edited.png

Prof. Jürgen Ruland

Professor

Director, Institute for Clinical Chemistry and Pathobiochemistry, Technical University of Munich

Dr_edited_edited_edited.png

Prof. Naoto Hirano

Senior Scientist
Chair, Immuno-Oncology Program
Princess Margaret Cancer Centre, University Health Network

Professor
Department of Immunology, University of Toronto

Associate Director for Research
Tumor Immunotherapy Program, Princess Margaret Cancer Centre

Liwei Lu_without background.png

Prof. Liwei Lu

Project Leader
Centre for Oncology and Immunology Ltd.

Professor (Immunology)
Department of Pathology,
The University of Hong Kong

Dr Carmen Wong_without background.png

Prof. Carmen Wong

Programme Leader
Centre for Oncology and Immunology Ltd.

Associate Professor

Department of Pathology, The University of Hong Kong

_edited_edited_edited_edited.png

Prof. Tak Mak

Co-Director (Scientific)
Centre for Oncology and Immunology Ltd.

Professor
Department of Medical Biophysics and Immunology, University of Toronto

Senior Scientist
Princess Margaret Cancer Centre, University Health Network

Honorary Professor
Department of Pathology, The University of Hong Kong

Lisa Butterfield_without background (1).png

Prof. Lisa Butterfield

Distinguished Scientist
Merck

tracy_without bg.png

Prof. Tracy McGaha

Senior Scientist
Princess Margaret Cancer Centre, University Health Network

Professor
Department of Immunology, University of Toronto

Dr El Helali Aya_without background.png

Prof. Aya El Helali

Clinical Assistant Professor

Department of Clinical Medicine, The University of Hong Kong

Agenda

Agenda

8:30AM - 9:10AM

Registration

9:10AM - 9:15AM

Welcome Remarks

Albert Wong |
Chief Executive Officer, Hong Kong Science and Technology Parks Corporation

9:15AM - 9:20AM

Opening Remarks

Tak Mak, Ph.D. | 
Co-Director, Centre for Oncology and Immunology

9:20AM - 9:30AM

Group Photo

Session 1 

Highlight Session 1

9:30AM - 10:25AM

GZMK-expressing CD8 T cells in chronic inflammatory diseases

Hai Qi, Ph.D |
Professor, Tsinghua University

10:25AM - 10:55AM

Break and Networking / Poster Session 1 

Panel Discussion 1

11:50AM - 12:20PM

Future Directions and Challenges in Cancer Immunotherapy 
Panel moderators:  Prof. Tracy McGaha & Prof. Carmen Wong

Hai Qi, Ph.D |
​Professor, Tsinghua University

Stephen Schoenberger, Ph.D. |

Professor, La Jolla Institute for Immunology

Liwei Lu, Ph.D. |
Project Leader, Centre for Oncology and Immunology Ltd.

Aya El Helali, MB BCh, MRCP, Ph.D. |

Clinical Assistant Professor, The University of Hong Kong

Highlight Session 2

10:55AM - 11:50AM

The spontaneous neoantigen-specific CD4+ T cell response to a growing tumor is functionally and phenotypically diverse

Stephen Schoenberger, Ph.D. |
Professor, La Jolla Institute for Immunology
12:20PM - 2:00PM

Lunch and Networking / Poster Session 2 

Session 2

Highlight Session 3

2:00PM - 2:55PM

Cancer Vaccines, Individualized Therapies and Immune Biomarkers

Lisa Butterfield, Ph.D. |
Distinguished Scientist, Merck

Highlight Session 4

2:55PM - 3:45PM

Infections, immunity and B cell lymphomagenesis

Qiang Pan-Hammarström, M.D., Ph.D. | 
Professor, Karolinska Institutet

3:45PM - 4:15PM

Break and Networking / Poster Session 3

Panel Discussion 2

5:10PM - 5:40PM

Translating Immunotherapy Research into Clinical Applications
Panel moderators: Prof. Tak Mak &  Prof. Naoto Hirano

Mark Davis, Ph.D. |
Professor, Stanford University

Qiang Pan-Hammarström, M.D., Ph.D. |
Professor, Karolinska Institutet

Lisa Butterfield, Ph.D. |
Distinguished Scientist, Merck


Jürgen Ruland, Ph.D. |
Professor, Technical University of Munich 

Highlight Session 5

4:15PM - 5:10PM

Immune organoids to advance our understanding of autoimmunity, infection and vaccination in human beings

Mark Davis, Ph.D. | 
Professor, Stanford University

5:40PM - 5:45PM

Closing Remarks

Suet-Yi Leung, M.D. |
Co-Director, Centre for Oncology and Immunology

Co-organized by

Supported by

In Collaboration with

Platinum Sponsor

Novogene logo.png

Gold Sponsors

Large-Final.png
ATCG Logo Trans.PNG
Dasheng Biotech (Hong Kong) Limited.png
Epredia Hong Kong Limited.png
01基因集团_rgb_20240109_Artboard-02.png
Hong Kong Yuxiang Technology Limited.png
Medikonia 2021 New Logo Black_.png
Miltenyl Biotec.png
Tin Hang.png

Silver Sponsor

Dieckmann (Hong Kong) Chemical Industry Company.png

© 2025 by Centre for Oncology and Immunology

bottom of page